Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.52)
# 1,022
Out of 4,476 analysts
309
Total ratings
45.3%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Maintained: Buy | $100 | $37.44 | +167.09% | 33 | Jul 1, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $26 → $29 | $9.84 | +194.72% | 4 | Jun 30, 2026 | |
| HROW Harrow | Maintained: Buy | $88 | $42.74 | +105.90% | 7 | Jun 29, 2026 | |
| PHVS Pharvaris | Maintained: Buy | $46 | $33.86 | +35.85% | 6 | Jun 29, 2026 | |
| STO: VICO Vicore Pharma Holding AB (publ) | Initiated Coverage: Buy | kr 33.00 | $13.44 | +145.54% | 1 | Jun 8, 2026 | |
| ALGS Aligos Therapeutics | Maintained: Buy | $20 | $5.59 | +257.78% | 2 | May 28, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $266 | $146.63 | +81.41% | 3 | May 20, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $34 → $13 | $6.26 | +107.67% | 9 | May 18, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $15 | $4.23 | +254.61% | 2 | May 13, 2026 | |
| IFRX InflaRx | Maintained: Buy | $2 → $4 | $2.24 | +78.57% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $4.43 | +58.01% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $8.11 | -13.69% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.81 | +341.99% | 11 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $22.31 | +43.43% | 5 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.91 | +243.64% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.02 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $24.92 | +60.51% | 2 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | $250.00 | +352.00% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $22 | $14.00 | +57.14% | 7 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $43 | $15.00 | +186.67% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $34.83 | +40.68% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $312.78 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $13.09 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $103 | $131.27 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.65 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $17 | $5.17 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $51 | $94.34 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $56 | $23.07 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $77 | $125.59 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $0.666 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $3.84 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $78 | $17.56 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $113.51 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $528.10 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $5 | $0.1732 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $63.42 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $7.28 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.5704 | n/a | 10 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $7.34 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $216.12 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $60.08 | n/a | 12 | Jun 13, 2021 |
Viking Therapeutics
Jul 1, 2026
Maintained: Buy
Price Target: $100
Current: $37.44
Upside: +167.09%
BioCryst Pharmaceuticals
Jun 30, 2026
Maintained: Buy
Price Target: $26 → $29
Current: $9.84
Upside: +194.72%
Harrow
Jun 29, 2026
Maintained: Buy
Price Target: $88
Current: $42.74
Upside: +105.90%
Pharvaris
Jun 29, 2026
Maintained: Buy
Price Target: $46
Current: $33.86
Upside: +35.85%
Vicore Pharma Holding AB (publ)
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: $13.44
Upside: +145.54%
Aligos Therapeutics
May 28, 2026
Maintained: Buy
Price Target: $20
Current: $5.59
Upside: +257.78%
Belite Bio
May 20, 2026
Maintained: Buy
Price Target: $266
Current: $146.63
Upside: +81.41%
Wave Life Sciences
May 18, 2026
Maintained: Buy
Price Target: $34 → $13
Current: $6.26
Upside: +107.67%
Opus Genetics
May 13, 2026
Maintained: Buy
Price Target: $15
Current: $4.23
Upside: +254.61%
InflaRx
May 8, 2026
Maintained: Buy
Price Target: $2 → $4
Current: $2.24
Upside: +78.57%
May 8, 2026
Maintained: Buy
Price Target: $7
Current: $4.43
Upside: +58.01%
May 5, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $8.11
Upside: -13.69%
Apr 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.81
Upside: +341.99%
Apr 7, 2026
Maintained: Buy
Price Target: $32
Current: $22.31
Upside: +43.43%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.91
Upside: +243.64%
Apr 1, 2026
Maintained: Hold
Price Target: n/a
Current: $2.02
Upside: -
Mar 23, 2026
Maintained: Buy
Price Target: $40
Current: $24.92
Upside: +60.51%
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: $250.00
Upside: +352.00%
Mar 12, 2026
Rated: Buy
Price Target: $21 → $22
Current: $14.00
Upside: +57.14%
Feb 25, 2026
Reiterated: Buy
Price Target: $42 → $43
Current: $15.00
Upside: +186.67%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $34.83
Upside: +40.68%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $312.78
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $22
Current: $13.09
Upside: n/a
Nov 8, 2024
Maintained: Buy
Price Target: $93 → $103
Current: $131.27
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.65
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $22 → $17
Current: $5.17
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $24 → $51
Current: $94.34
Upside: n/a
Jan 3, 2024
Maintained: Buy
Price Target: $27 → $56
Current: $23.07
Upside: n/a
Oct 18, 2023
Maintained: Buy
Price Target: $84 → $77
Current: $125.59
Upside: n/a
Jun 23, 2023
Maintained: Buy
Price Target: $25 → $17
Current: $0.666
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $33 → $35
Current: $3.84
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $94 → $78
Current: $17.56
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $113.51
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $528.10
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $15 → $5
Current: $0.1732
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $38
Current: $63.42
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $7.28
Upside: n/a
May 18, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.5704
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $18
Current: $7.34
Upside: n/a
Jul 22, 2021
Maintained: Hold
Price Target: n/a
Current: $216.12
Upside: n/a
Jun 13, 2021
Maintained: Sell
Price Target: n/a
Current: $60.08
Upside: n/a